​

Disc Medicine (IRON) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

IRON Stock Forecast

Disc Medicine (IRON) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $106.00, with a high of $128.00 and a low of $86.00. This represents a 66.64% increase from the last price of $63.61.

- $30 $60 $90 $120 $150 High: $128 Avg: $106 Low: $86 Last Closed Price: $63.61

IRON Stock Rating

Disc Medicine stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 1 Strong Buy (9.09%), 10 Buy (90.91%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 10 1 Strong Sell Sell Hold Buy Strong Buy

IRON Price Target Upside V Benchmarks

TypeNameUpside
StockDisc Medicine66.64%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts3417
Avg Price Target$111.33$106.00$106.41
Last Closing Price$63.61$63.61$63.61
Upside/Downside75.02%66.64%67.29%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 26112---13
Sep, 26112---13
Aug, 26112---13
Jul, 26112---13
Jun, 26112---13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 16, 2026Derek ArchilaWells Fargo$86.00$67.3027.79%35.20%
Sep 10, 2026Douglas TsaoH.C. Wainwright$120.00$76.5156.84%88.65%
Sep 10, 2026Roger SongJefferies$128.00$76.5167.30%101.23%
Aug 17, 2026Morgan Stanley$90.00$78.8714.11%41.49%
Jun 15, 2026Morgan Stanley$85.00$70.0921.27%33.63%
May 14, 2026Morgan Stanley$80.00$69.3015.44%25.77%
Feb 17, 2026Wedbush$88.00$60.2845.99%38.34%
Feb 17, 2026Kristen KluskaCantor Fitzgerald$125.00$60.24107.50%96.51%
Feb 17, 2026Morgan Stanley$75.00$60.3924.19%17.91%
Feb 17, 2026Stifel Nicolaus$110.00$61.4379.07%72.93%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 16, 2026Wells FargoOverweightOverweighthold
Sep 10, 2026H.C. WainwrightBuyBuyhold
Sep 10, 2026BMO CapitalOutperformOutperformhold
Sep 10, 2026JefferiesBuyBuyhold
Sep 01, 2026Cantor FitzgeraldOverweightOverweighthold
Aug 17, 2026Morgan StanleyOverweightOverweighthold
Jun 15, 2026Morgan StanleyOverweightOverweighthold
May 14, 2026Morgan StanleyOverweightOverweighthold
Mar 02, 2026Wells FargoOverweightOverweighthold
Feb 17, 2026Cantor FitzgeraldOverweightOverweighthold

Financial Forecast

EPS Forecast

$-10 $-7 $-4 $-1 $2 $5 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.42$-3.96$-6.01---
Avg Forecast$-3.25$-4.13$-5.21$-5.35$-4.12$-0.32
High Forecast$-2.96$-3.94$-4.20$-3.89$2.49$-0.32
Low Forecast$-3.58$-4.50$-6.08$-8.11$-8.83$-0.32
Surprise %5.23%-4.12%15.36%---

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$6.06M$38.61M$117.86M$308.23M
High Forecast--$6.07M$38.61M$117.86M$308.23M
Low Forecast--$6.04M$38.61M$117.86M$308.23M
Surprise %------

Net Income Forecast

$-250M $-180M $-110M $-40M $30M $100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-76.43M$-109.36M$-212.18M---
Avg Forecast$-76.43M$-94.10M$-114.74M$-178.09M$-145.87M$-7.04M
High Forecast$-66.05M$-87.87M$-93.71M$-86.87M$55.55M$-7.04M
Low Forecast$-79.93M$-100.32M$-135.76M$-181.01M$-197.16M$-7.04M
Surprise %-16.22%84.93%---

IRON Forecast FAQ

Is Disc Medicine stock a buy?

Disc Medicine stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 10 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Disc Medicine is a favorable investment for most analysts.

What is Disc Medicine's price target?

Disc Medicine's price target, set by 11 Wall Street analysts, averages $106 over the next 12 months. The price target range spans from $86 at the low end to $128 at the high end, suggesting a potential 66.64% change from the previous closing price of $63.61.

How does Disc Medicine stock forecast compare to its benchmarks?

Disc Medicine's stock forecast shows a 66.64% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Disc Medicine over the past three months?

  • October 2026: 7.69% Strong Buy, 92.31% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 7.69% Strong Buy, 92.31% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 7.69% Strong Buy, 92.31% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Disc Medicine’s EPS forecast?

Disc Medicine's average annual EPS forecast for its fiscal year ending in December 2026 is $-5.35, marking a -10.98% decrease from the reported $-6.01 in 2025. Estimates for the following years are $-4.12 in 2027, and $-0.32 in 2028.

What is Disc Medicine’s revenue forecast?

Disc Medicine's average annual revenue forecast for its fiscal year ending in December 2026 is $38.61M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $117.86M, and $308.23M for 2028.

What is Disc Medicine’s net income forecast?

Disc Medicine's net income forecast for the fiscal year ending in December 2026 stands at $-178M, representing a -16.07% decrease from the reported $-212M in 2025. Projections indicate $-146M in 2027, and $-7.041M in 2028.